Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 1631 entries
View as:

Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02803060 Org: User:
Start: 11/09/15 End: 11/17/15 Due: 11/17/16

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

Phase: N/A Priority: Normal
NCT ID: NCT00910637 Org: User:
Start: 05/01/09 End: 12/13/10 Due: 12/13/11

Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa

Phase: N/A Priority: Normal
NCT ID: NCT00280657 Org: User:
Start: 03/10/04 End: 05/21/05 Due: 05/21/06

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

Phase: N/A Priority: Normal
NCT ID: NCT02413515 Org: User:
Start: 03/26/15 End: 08/08/16 Due: 08/08/17

Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT02342665 Org: User:
Start: 04/21/15 End: 02/10/22 Due: 02/10/23

Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01565746 Org: User:
Start: 03/31/12 End: 04/30/16 Due: 04/30/17

BAY94-9027 PK Study Comparing to Another Long Acting Product

Phase: N/A Priority: Normal
NCT ID: NCT03364998 Org: User:
Start: 11/30/17 End: 09/28/18 Due: 09/28/19

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00674115 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients

Phase: N/A Priority: Normal
NCT ID: NCT03310645 Org: User:
Start: 12/07/17 End: 06/19/19 Due: 06/19/20

Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01187615 Org: User:
Start: 08/31/10 End: 06/30/12 Due: 06/30/13

Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging

Phase: N/A Priority: Normal
NCT ID: NCT00709852 Org: User:
Start: 06/30/08 End: 04/30/09 Due: 04/30/10

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study

Phase: N/A Priority: Normal
NCT ID: NCT00440193 Org: User:
Start: 03/31/07 End: 04/30/10 Due: 04/30/11

Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05517746 Org: User:
Start: 12/18/19 End: 03/11/21 Due: 03/11/22

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00606125 Org: User:
Start: 05/31/07 End: 02/28/09 Due: 02/28/10

Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00786253 Org: User:
Start: 10/31/05 End: 01/31/07 Due: 01/31/08

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Phase: N/A Priority: Normal
NCT ID: NCT02710708 Org: User:
Start: 05/27/16 End: 07/03/18 Due: 07/03/19

Observational Study of Ultravist in Patients Requiring CECT

Phase: N/A Priority: Normal
NCT ID: NCT01415414 Org: User:
Start: 09/30/11 End: 11/30/13 Due: 11/30/14

Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.

Phase: N/A Priority: Normal
NCT ID: NCT04027192 Org: User:
Start: 07/31/19 End: 11/16/20 Due: 11/16/21

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02639091 Org: User:
Start: 02/03/16 End: 10/17/19 Due: 10/17/20

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

Phase: N/A Priority: Normal
NCT ID: NCT01294215 Org: User:
Start: 02/28/11 End: 06/30/12 Due: 06/30/13

Endometrial Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT00522873 Org: User:
Start: 08/31/07 End: 08/31/09 Due: 08/31/10

Maintenance Treatment of Renal Anemia in Dialysis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03543657 Org: User:
Start: 06/23/18 End: 12/24/19 Due: 12/24/20

Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02822313 Org: User:
Start: 11/23/15 End: 12/03/15 Due: 12/03/16

18790 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02695303 Org: User:
Start: 02/23/16 End: 02/25/16 Due: 02/25/17

A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06329895 Org: User:
Start: 03/25/24 End: 06/10/24 Due: 06/10/25